CATB - Catabasis Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts3333
Avg. Estimate-0.7-0.69-2.71-2.34
Low Estimate-0.9-0.96-3.55-2.68
High Estimate-0.53-0.52-2.09-2.02
Year Ago EPS-2.9-2-5.12-2.71
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-2.01-2.34-1.35-0.9
EPS Actual-2.9-2-0.8-1.2
Difference-0.890.340.55-0.3
Surprise %-44.30%14.50%40.70%-33.30%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.7-0.69-2.71-2.34
7 Days Ago-0.73-0.76-3.35-3.01
30 Days Ago-0.9-0.93-3.78-3.33
60 Days Ago-0.9-0.93-3.78-3.5
90 Days Ago-0.09-0.09-0.39-0.38
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1111
Up Last 30 Days1122
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCATBIndustrySectorS&P 500
Current Qtr.75.90%N/AN/A-0.01
Next Qtr.65.50%N/AN/A0.05
Current Year47.10%N/AN/A0.05
Next Year13.70%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A